Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda.
about
Decision modeling of disagreements: pediatric hematologists' management of idiopathic thrombocytopenic purpura.A new method for determining physician decision thresholds using empiric, uncertain recommendations.How do physicians decide to treat: an empirical evaluation of the threshold model.Intuitive weights of harm for therapeutic decision making in smear-negative pulmonary Tuberculosis: an interview study of physicians in India, Pakistan and Bangladesh.Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosisCharacteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence.When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation.Rationality, practice variation and person-centred health policy: a threshold hypothesis.Weighing harm in therapeutic decisions of smear-negative pulmonary tuberculosis.Bayesian clinical reasoning: does intuitive estimation of likelihood ratios on an ordinal scale outperform estimation of sensitivities and specificities?Many faces of rationality: Implications of the great rationality debate for clinical decision-making.An inquiry about clinicians' view of the distribution of posttest probabilities: possible consequences for applying the threshold concept.A novel approach to the determination of clinical decision thresholds.Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold.Rational decision making in medicine: Implications for overuse and underuse.The balance beam metaphor: a perspective on clinical diagnosis.Threshold analysis in the presence of both the diagnostic and the therapeutic risk.
P2860
Q33394489-4C52DD03-81BD-4AA1-9E66-BD4B26518553Q33551018-EB26CAF4-D52E-4BA0-BEFB-6F1D2F4F81A1Q33747436-4821810A-8E5C-417D-972D-BBC196C24583Q34021616-AF6C0CAD-CB4F-4C49-982E-569C6AD3111EQ34614614-E192367B-F67A-4EF5-83B6-E114F7435F63Q35129505-DFF8D6E9-D49A-4D61-9AC2-E340BE171D94Q35903504-EC79BD2A-A6A7-48B6-9447-3DD29A76C1F9Q38353140-9ABA1985-4D93-4870-B199-3432F6EF9E7FQ38974508-3B3449B1-8B7C-455F-A117-F37C08CF0894Q39267642-B9FC9E83-1BEB-446E-AF9F-423E1A3DB760Q39267649-4C38CA58-6837-4CEC-BEE3-E3FA9B7DB8B2Q39449880-CB62B556-E807-47E3-84D7-65ABB255A8A9Q39548590-7D434328-0D4C-4A30-BD15-931BF4610075Q41307375-CB79AA9C-8980-4A0D-BF23-42E45A30827DQ42375069-99FE245B-C125-4E0B-9CF3-FDDC5325DFCBQ46606910-3799D780-69DC-466C-8380-925A09294D85Q48079568-2AE423C8-6536-4692-996D-1D525940F59FQ49564522-EB905419-F658-4116-88CB-4661883B4996
P2860
Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@en
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@nl
type
label
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@en
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@nl
prefLabel
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@en
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@nl
P2093
P2860
P356
P1476
Why are clinicians reluctant t ...... reatment thresholds in Rwanda.
@en
P2093
Jef Van den Ende
Juan Moreira
Paulin Basinga
Zeno Bisoffi
P2860
P356
10.1177/0272989X06297104
P577
2007-01-01T00:00:00Z